Angioscopic Evaluation of Atrial Septal Defect Closure Device Neo‐Endothelialization

Angioscopic Evaluation of Atrial Septal Defect Closure Device Neo‐Endothelialization

Background Current guidelines recommend at least 6 months of antithrombotic therapy and antibiotic prophylaxis after septal‐occluding device deployment in transcatheter closure of atrial septal defect. It has been estimated that it takes ≈6 months for complete neo‐endothelialization; however, neo‐en...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yasuhiro Tanabe, Tomomi Suzuki, Shingo Kuwata, Masaki Izumo, Hiromasa Kawaguchi, Shun Ogoda, Nozomi Kotoku, Yukio Sato, Haruka Nishikawa, Toshiki Kaihara, Masashi Koga, Takanobu Mitarai, Kazuaki Okuyama, Ryo Kamijima, Yuki Ishibashi, Kihei Yoneyama, Takumi Higuma, Tomoo Harada, Yoshihiro J. Akashi
Format: article
Langue:EN
Publié: Wiley 2021
Sujets:
angioscopy
atrial septal defect
device neo‐endothelialization
Diseases of the circulatory (Cardiovascular) system
RC666-701
Accès en ligne:https://doaj.org/article/f70c2f2215d84c93b17bb5c1d3262b15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/f70c2f2215d84c93b17bb5c1d3262b15

Documents similaires